Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer

Objective The Neck Imaging Reporting and Data System (NI-RADS) is a standardized numerical reporting template for surveillance of head and neck squamous cell carcinoma (HNSCC). Our aim was to analyze the accuracy of NI-RADS on the first posttreatment fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography (PET/CECT). Study Design Retrospective cohort study. Setting Academic tertiary hospital. Subject and Methods Patients with HNSCC with a 12-week posttreatment PET/CECT interpreted using the NI-RADS template and 9 months of clinical and radiologic follow-up starting from treatment completion between June 2014 and July 2016 were included. Treatment failure was defined as positive tumor confirmed by biopsy or Response Evaluation Criteria in Solid Tumors criteria. Cox proportional hazards models were performed. Results This study comprised 199 patients followed for a median of 15.5 months after treatment completion (25% quartile, 11.8 months; 75% quartile, 20.2 months). The rates of treatment failure increased with each incremental increase in NI-RADS category from 1 to 3 (4.3%, 9.1%, and 42.1%, respectively). A Cox proportional hazards model demonstrated a strong association between NI-RADS categories and treatment failure at both primary and neck sites (hazard ratio [HR], 2.60 and 5.22, respectively; P < .001). In the smaller treatment subgroup analysis, increasing NI-RADS category at the primary site in surgically treated patients and treatment failure did not achieve statistically significant association (HR, 0.88; P = .82). Conclusion Increasing NI-RADS category at the baseline posttreatment PET/CECT is strongly associated with increased risk of treatment failure in patients with HNSCC.

[1]  R. Wiggins,et al.  ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee. , 2018, Journal of the American College of Radiology : JACR.

[2]  P. Hudgins,et al.  Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma , 2017, American Journal of Neuroradiology.

[3]  P. Hudgins,et al.  Implementation of a Novel Surveillance Template for Head and Neck Cancer: Neck Imaging Reporting and Data System (NI-RADS). , 2016, Journal of the American College of Radiology : JACR.

[4]  Seungwon Kim,et al.  Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma , 2016, Head & neck.

[5]  S. Sheikhbahaei,et al.  FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy. , 2016, AJR. American journal of roentgenology.

[6]  J. Seibert,et al.  Reengineering the radiology enterprise: a summary of the 2014 Intersociety Committee Summer Conference. , 2015, Journal of the American College of Radiology : JACR.

[7]  J. Gaughan,et al.  Predictive accuracy of first post‐treatment PET/CT in HPV‐related oropharyngeal squamous cell carcinoma , 2014, The Laryngoscope.

[8]  D. Heron,et al.  Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer , 2013, American Journal of Neuroradiology.

[9]  M. Kaplan,et al.  Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence , 2013, Cancer.

[10]  Wei Xu,et al.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Aiken Pitfalls in the staging of cancer of oral cavity cancer. , 2013, Neuroimaging clinics of North America.

[12]  S. Larson,et al.  Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer , 2008, Journal of Nuclear Medicine.

[13]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[14]  정기동,et al.  Recurrence , 1946, Definitions.

[15]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.